165 related articles for article (PubMed ID: 17132416)
21. The value-based medicine comparative effectiveness and cost-effectiveness of penetrating keratoplasty for keratoconus.
Roe RH; Lass JH; Brown GC; Brown MM
Cornea; 2008 Oct; 27(9):1001-7. PubMed ID: 18812762
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of tacrolimus ointment vs. standard treatment in patients with moderate and severe atopic dermatitis: a health-economic model simulation based on a patient survey and clinical trial data.
Hjelmgren J; Svensson A; Jörgensen ET; Lindemalm-Lundstam B; Ragnarson Tennvall G
Br J Dermatol; 2007 May; 156(5):913-21. PubMed ID: 17263826
[TBL] [Abstract][Full Text] [Related]
23. Clinical and cost-effectiveness of primary prevention of Type 2 diabetes in a 'real world' routine healthcare setting: model based on the KORA Survey 2000.
Icks A; Rathmann W; Haastert B; Gandjour A; Holle R; John J; Giani G;
Diabet Med; 2007 May; 24(5):473-80. PubMed ID: 17381502
[TBL] [Abstract][Full Text] [Related]
24. Adjustable gastric band placed around gastric bypass pouch as revision operation for failed gastric bypass.
Chin PL; Ali M; Francis K; LePort PC
Surg Obes Relat Dis; 2009; 5(1):38-42. PubMed ID: 18996754
[TBL] [Abstract][Full Text] [Related]
25. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
Oldridge N; Furlong W; Perkins A; Feeny D; Torrance GW
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):608-15. PubMed ID: 18800005
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the association between the EQ-5D (health-related utility) and body mass index (obesity) in hospital-treated people with Type 1 diabetes, Type 2 diabetes and with no diagnosed diabetes.
Lee AJ; Morgan CL; Morrissey M; Wittrup-Jensen KU; Kennedy-Martin T; Currie CJ
Diabet Med; 2005 Nov; 22(11):1482-6. PubMed ID: 16241910
[TBL] [Abstract][Full Text] [Related]
27. [Assessment of the budgetary impact of treatment guidelines in type II diabetes mellitus in France].
Marissal JP; Sailly JC; Crainich D; Lebrun T
Rev Epidemiol Sante Publique; 2005 Sep; 53 Spec No 1():1S67-78. PubMed ID: 16327742
[TBL] [Abstract][Full Text] [Related]
28. Cost-Utility Analysis of Bariatric Surgery in Italy: Results of Decision-Analytic Modelling.
Lucchese M; Borisenko O; Mantovani LG; Cortesi PA; Cesana G; Adam D; Burdukova E; Lukyanov V; Di Lorenzo N
Obes Facts; 2017; 10(3):261-272. PubMed ID: 28601866
[TBL] [Abstract][Full Text] [Related]
29. [Economic analysis and public health. Why does one need economic evaluation applied to diabetes? What methods does one choose: cost effectiveness, cost utility, cost benefit? Are such studies useful in terms of public health?].
Triomphe A
Diabete Metab; 1993 Dec; 19(5 Suppl):473-6. PubMed ID: 8206181
[TBL] [Abstract][Full Text] [Related]
30. The impact of morbid obesity on the state economy: an initial evaluation.
Frezza EE; Wachtel MS; Ewing BT
Surg Obes Relat Dis; 2006; 2(5):504-8. PubMed ID: 17015201
[TBL] [Abstract][Full Text] [Related]
31. Is bariatric surgery worth its costs?
Hauri P; Horber FF; Sendi P
Obes Surg; 1999 Oct; 9(5):480-3. PubMed ID: 10605907
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of Roux-en-Y gastric bypass in type 2 diabetes patients.
Ikramuddin S; Klingman D; Swan T; Minshall ME
Am J Manag Care; 2009 Sep; 15(9):607-15. PubMed ID: 19747025
[TBL] [Abstract][Full Text] [Related]
33. Cost-effective bariatric surgery in Germany today.
Kuhlmann HW; Falcone RA; Wolf AM
Obes Surg; 2000 Dec; 10(6):549-52. PubMed ID: 11175964
[TBL] [Abstract][Full Text] [Related]
34. Cost analysis of bariatric surgery in Denmark made with a decision-analytic model.
Borisenko O; Lukyanov V; Johnsen SP; Funch-Jensen P
Dan Med J; 2017 Aug; 64(8):. PubMed ID: 28869031
[TBL] [Abstract][Full Text] [Related]
35. Long-term cost-effectiveness of weight management in primary care.
Trueman P; Haynes SM; Felicity Lyons G; Louise McCombie E; McQuigg MS; Mongia S; Noble PA; Quinn MF; Ross HM; Thompson F; Broom JI; Laws RA; Reckless JP; Kumar S; Lean ME; Frost GS; Finer N; Haslam DW; Morrison D; Sloan B;
Int J Clin Pract; 2010 May; 64(6):775-83. PubMed ID: 20353431
[TBL] [Abstract][Full Text] [Related]
36. Budget impact analysis of surgical treatment for obesity in Sweden.
Borg S; Näslund I; Persson U; Odegaard K
Scand J Surg; 2012; 101(3):190-7. PubMed ID: 22968243
[TBL] [Abstract][Full Text] [Related]
37. Weight loss surgery for mild to moderate obesity: a systematic review and economic evaluation.
Picot J; Jones J; Colquitt JL; Loveman E; Clegg AJ
Obes Surg; 2012 Sep; 22(9):1496-506. PubMed ID: 22926715
[TBL] [Abstract][Full Text] [Related]
38. Direct and indirect costs and potential cost savings of laparoscopic adjustable gastric banding among obese patients with diabetes.
Finkelstein EA; Allaire BT; DiBonaventura MD; Burgess SM
J Occup Environ Med; 2011 Sep; 53(9):1025-9. PubMed ID: 21866052
[TBL] [Abstract][Full Text] [Related]
39. Pros and cons of gastric bypass surgery in individuals with obesity and type 2 diabetes: nationwide, matched, observational cohort study.
Liakopoulos V; Franzén S; Svensson AM; Miftaraj M; Ottosson J; Näslund I; Gudbjörnsdottir S; Eliasson B
BMJ Open; 2019 Jan; 9(1):e023882. PubMed ID: 30782717
[TBL] [Abstract][Full Text] [Related]
40. The impact of body weight on patient utilities with or without type 2 diabetes: a review of the medical literature.
Dennett SL; Boye KS; Yurgin NR
Value Health; 2008; 11(3):478-86. PubMed ID: 18489671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
